Merck Plans Gardasil Campaign Targeting “Mid-adult” Women
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA clears Pennsylvania manufacturing plant; vaccine sBLAs, including one for Gardasil in “older” women, can proceed.
You may also be interested in...
Gardasil Label Expansion To Women 27-45 Delayed Until 2010, At The Earliest
Merck receives a second “complete response” letter from FDA related to its sBLA to extend indications for the vaccine to older women.
Gardasil Label Expansion To Women 27-45 Delayed Until 2010, At The Earliest
Merck receives a second “complete response” letter from FDA related to its sBLA to extend indications for the vaccine to older women.
Merck Compensates Docs For Gardasil For Adult Women When Insurers Do Not
Merck is encouraging physicians to provide the Gardasil human papillomavirus vaccine to young adult women by cushioning the risk that health plans may deny reimbursement for such patients